Treeline Biosciences
Treeline Biosciences raises $200M Series A
Quick Facts
Treeline Biosciences: Series A Funding Round
Treeline Biosciences has successfully raised $200M in Series A funding.
Company Overview
Developer of medicines for cancer and serious diseases, total funding $1.1B
Funding Details
The Series A round was led by Multiple investors.
Company Information
- Headquarters: Watertown, MA
- Founded: 2021
- Employees: 120+
- Category: HealthTech
Investment
Treeline Biosciences plans to use the funds to accelerate product development, expand its team, and scale operations globally.
About the Investors
- Multiple investors: Verified investor in Series A
Key Investors
About the Author
Related Company Reports
Abridge Raises $150M Series C to Transform HealthTech
Abridge has secured $150M Series C in funding to accelerate growth and innovation in the healthtech sector. Medical AI scribe platform automatically documenting patient-provider conversations and generating clinical notes...
Innovaccer Raises $275M Series F to Transform HealthTech
Innovaccer has secured $275M Series F in funding to accelerate growth and innovation in the healthtech sector. Healthcare data platform unifying patient data and providing analytics for value-based care and population health manage...
Truveta Raises $95M Series B to Transform HealthTech
Truveta has secured $95M Series B in funding to accelerate growth and innovation in the healthtech sector. Healthcare data platform aggregating de-identified patient records to accelerate medical research and drug development...
